About Pharmallama
Pharmallama is a Healthcare company based in Bengaluru (India) founded in 2020 by Achintya Dayal, Arjun Raghunandan, and Deepesh Rajpal. Online platform for the purchase of medicines. Pharmallama has raised $483.56 thousand across 2 funding rounds from investors including Aman Gupta, Amit Jain and Anupam Mittal. The company has 16 employees. Its Indian entity Meradawai Private Limited reported revenue of ₹4.6 Lakh. Pharmallama offers products and services including Pre-sorted Medicine Packs and Mobile App. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its competitors include Digi-Prex, MetroMedi and Apkamedical; 2 of its 3 listed competitors have raised funding.
Company details
Pharmallama, backed by 241518.0 from Aman Gupta, Amit Jain, Anupam Mittal, Namita Thapar, Peyush Bansal, focuses on healthtech, healthcare booking platforms, pharmacies, drugs, diversified, and subscription. Online platform for the purchase of medicines. Driving innovation, growth, and excellence in its industry sectors.
- Headquarters Bengaluru, India
- Employees 16
- Founders Achintya Dayal, Arjun Raghunandan, Deepesh Rajpal
- SectorsHealthcare
- Email••••••••
- Website pharmallama.com
- Social LinkedIn X Facebook
- Legal Name Meradawai Private Limited
- Date of Incorporation 27 Jul, 2020
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹4.6 Lakh
FY 2024 · -94% YoY
- Net Loss-₹1.94 Cr
FY 2024 · -4231% margin
- EBITDA-₹1.92 Cr
FY 2024 · -4193% margin
- Total Equity Funding$483.56K (USD)
in 2 rounds
- Latest Funding Round$242.04K (USD), Angel Round
Mar 2023
- Employee Count16
Associated legal entities of Pharmallama
Pharmallama operates through Meradawai Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Meradawai Private Limited CIN U52310MH2020PTC342736 | Active | 27 Jul 2020 | Mumbai, Maharashtra | ₹0.0 Cr | 16 | 3 | View details |
Products & Services of Pharmallama
Pharmallama offers a comprehensive portfolio of products and services, including Pre-sorted Medicine Packs and Mobile App.
Service for arranging medicines per prescriptions with safe packaging.
App for medication reminders, tracking, and expert consultations.
Funding Insights of Pharmallama
Pharmallama has successfully raised a total of $483.56K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $242.04 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $483,556
- Total Rounds 2
- Last Round Angel Round — $242,038
- First Round $241,518
(Feb 2023)
- Investors Count 5
All 2 funding rounds of Pharmallama with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $242,038 | Angel Round | – | – | – |
| Feb 2023 | $241,518 | Angel Round | – | Aman Gupta, Amit Jain | – |
5 investors in total: 0 institutional and 5 angel.
Investors in Pharmallama
Pharmallama has secured backing from 5 investors, including angel investors. Prominent investors backing the company include Aman Gupta, Amit Jain and Anupam Mittal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AG Aman Gupta | Co-founder of boAt, Shark Tank India judge, active angel investor | unknown_7e7372e8b0144d078 | ||
AJ Amit Jain | CEO of CarDekho, prominent angel investor in Indian startups | unknown_4bbac542bdb64fedb | ||
AM Anupam Mittal | Founder of Shaadi.com, angel investor, Shark Tank India judge | unknown_84b4ce1051d240c9a | ||
NT Namita Thapar | Executive Director at Emcure Pharmaceuticals, angel investor, Shark Tank India judge | unknown_3993373643614ee29 | ||
PB Peyush Bansal | Founder of Lenskart, prominent angel investor, Shark Tank India judge | unknown_14524346149a4f308 |
Investor details for Pharmallama
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Meradawai Private Limited (Pharmallama)
Meradawai Private Limited is the primary company behind Pharmallama. The board of Meradawai Private Limited currently have 3 directors; the longest-serving is Arjun Raghunandan, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arjun Raghunandan DIN 07310862 | Director | 27 Jul 2020 | 6 yrs 2 mo | Meradawai Private Limited |
| Achintya Dayal Srivastav DIN 07325144 | Director | 27 Jul 2020 | 6 yrs 2 mo | Meradawai Private Limited |
| Deepesh Rajpal DIN 06708950 | Director | 15 May 2023 | 3 yrs 5 mo | Meradawai Private Limited |
People of Pharmallama
4 people are tracked at Pharmallama (3 in leadership, 1 in team); the tracked headcount is 16.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Karan Singh | Investor & Advisor | Team |
Complete people profiles for Pharmallama
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Pharmallama
Figures of Meradawai Private Limited, the primary company behind Pharmallama, for FY 2024. Revenue was ₹4.6 Lakh (-94% year on year). Net loss was -₹1.94 Cr (-4231% margin). EBITDA was -₹1.92 Cr (-4193% margin). Revenue has grown at a compounded annual rate of +2328% over three years.
- ₹4.6 LakhRevenue · FY 2024 · -94% YoY
- -₹1.94 CrNet loss · -4231% margin
- -₹1.92 CrEBITDA · -4193% margin
- ₹6.00 CrPaid-up capital
- 16Employees (provident fund records)
- +2328%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Meradawai Private Limited are on its company page.
Detailed financial statements for Pharmallama
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Pharmallama
3 dated milestones of Pharmallama across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmallama is founded.
- Funding First funding round of $242K.
- Funding Latest funding round, Angel Round, of $242K.
Competitors of Pharmallama
Pharmallama has 3 listed competitors in our database, 2 of them funded. They include Digi-Prex, MetroMedi and Apkamedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| digi-prex.com | 2019 | Hyderabad, India | $5.5M | 5 | Prescriptions are uploaded online for medicine delivery and reordering. | |
| metromedi.com | 2018 | Hyderabad, India | $1.95M | 17 | Online drug store products for healthcare and nutrition are provided. | |
| apkamedical.com | 2020 | Morena, India | Operates a digital marketplace for online medicine purchases. |
Detailed competitors of Pharmallama
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pharmallama
The website of Pharmallama (pharmallama.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 4.2% vs previous month
Top companies in Digital Health & Telemedicine
3 companies that operate in the same segment as Pharmallama (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of an online pharmacy with doctor listing and teleconsultation services | 2015 | Delhi, Delhi, India | USD 230.8 M | USD 328.97 M | 5,212 | |
Online platform offering multiple healthcare services | 2013 | Bengaluru, Karnataka, India | USD 199.22 M | USD 62.4 M | 52 | |
An online marketplace for healthcare products is operated. | 2011 | Kolkata, West Bengal, India | USD 38.26 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmallama
Complete news archive for Pharmallama
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmallama
Pharmallama was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Pharmallama is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Pharmallama is a funded company, having raised a total of $483.56K across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $241.52K, raised on Feb 2023.
Pharmallama has 16 employees.
The primary company behind Pharmallama, Meradawai Private Limited, reported revenue of ₹4.6 Lakh for FY 2024, down 94% year on year.
Pharmallama, backed by 241518.0 from Aman Gupta, Amit Jain, Anupam Mittal, Namita Thapar, Peyush Bansal, focuses on healthtech, healthcare booking platforms, pharmacies, drugs, diversified, and subscription. Online platform for the purchase of medicines. Driving innovation, growth, and excellence in its industry sectors.
Pharmallama's top competitors include Digi-Prex, MetroMedi and Apkamedical.
Pharmallama offers Pre-sorted Medicine Packs and Mobile App.
Pharmallama has 5 investors. Key investors include Aman Gupta, Amit Jain, Anupam Mittal, Namita Thapar, and Peyush Bansal.
Pharmallama operates through Meradawai Private Limited.
The legal entities of Pharmallama currently have 3 directors, including Arjun Raghunandan, Achintya Dayal Srivastav, Deepesh Rajpal.